Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
microbiome
Biotech
MaaT posts 18-month data showing 'clear OS advantage' in aGvHD
The microbiome biotech has touted long-term data as proof it’s on track to launch the drug in acute graft-versus-host disease in two years’ time.
James Waldron
Apr 15, 2024 7:05am
Clinical Microbiomics snaps up DNASense
Mar 1, 2024 9:00am
Genome & Co. posts data from phase 2 microbiome cancer trial
Jan 24, 2024 9:39am
Flagship-founded Evelo finds dissolution is only viable option
Nov 22, 2023 7:37am
Seres slims R&D, staff to focus on approved microbiome drug
Nov 2, 2023 12:22pm
Evelo hits new low as psoriasis flop sparks hunt for alternative
Oct 17, 2023 8:25am